News
Introduction The development of the share price for Bridge Investment Group Holdings Inc. (NYSE:BRDG) over the last 12 months has been anything but impressive...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Follow Q1: 2026-05-12 Earnings Summary EPS of -$0.04 beats by $0.06 | Revenue of $9.65M (-7.11% Y/Y) beats by $2.35M MaxCyte, Inc. (MXCT) Q1 2026...
News
Rolly Bustos All right. I think to respect everybody’s time, I think we will get started here. So again, greetings, and welcome to all...
News
Fidelity’s mission is to strengthen the financial well-being of our customers and deliver better outcomes for the clients and businesses it serves. With assets...
News
This article series aims at evaluating ETFs (exchange-traded funds) regarding past performance and portfolio metrics. Reviews with updated data are posted when necessary. DTD...
News
I have previously written about the resurgence of scam trusts in my article The Complex Trust Is Simply The Criminal Tax Evasion Device Known...
News
In my most recent article on the Brazilian water and waste management company, SABESP (NYSE:SBS), operating in the state of São Paulo, I maintained...
News
Research Summary Today I’ll be rating Stifel Financial (NYSE:SF), in the financials sector, investment banking & brokerage subsector. It had its Q2 earnings result...
News
Mettler-Toledo International (NYSE:MTD) is a prominent manufacturer of laboratory balances, liquid pipetting solutions, and automated laboratory reactors, serving both the healthcare and industrial sectors....
News
“Vishing’ is a double-layered scam. It could start with a phone call stating “your grandson is in trouble and needs money.” Then the caller...
News
Listen below or on the go on Apple Podcasts and Spotify Chris DeMuth Jr. talks about investing in 2023, the current state of the...
News
I provide monthly overviews for orders, cancellations, deliveries, and other order book mutations for Airbus SE (OTCPK:EADSF, OTCPK:EADSY). While the release of monthly orders...
News
I covered Stoke Therapeutics (NASDAQ:STOK) in February, and although I was mildly positive, I am lucky I didn’t go out and buy the stock...
